Market Insights

Global Pharmaceutical Contract Manufacturing Market Expected to Exceed USD 360 Billion by 2032 | DelveInsight

The pharmaceutical contract manufacturing market is witnessing robust growth, largely fueled by the increasing prevalence of chronic and infectious diseases. This expansion is further supported by the growing demand for biologics and biopharmaceuticals. Additionally, pharmaceutical and biotechnology companies are actively strengthening their
20 November 2025

Myelofibrosis Market Poised to Expand Significantly at 9% CAGR from 2025 to 2034 | DelveInsight

The introduction of novel therapies, including BESREMi (PharmaEssentia/AOP Orphan Pharmaceuticals), INCB057643 (Incyte), XPOVIO (Karyopharm Therapeutics), RYTELO (Geron), REBLOZYL (Bristol Myers Squibb), Navtemadlin (Kartos Therapeutics), Pelabresib (Novartis), among others, is poised to reshape the myelofibrosis treatment landscape. DelveInsight’s Myelofibrosis Market Insights report includes
19 November 2025

Hi There!

Eu qui dicat praesent iracundia, fierent partiendo referrentur ne est, ius ea falli dolor copiosae. Usu atqui veniam ea, his oportere facilisis suscipiantur ei. Qui in meliore conceptam, nam esse option eu. Oratio voluptatibus ex vel.

Banner

Latest Interviews

Newsletter